These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 33832807)

  • 1. AML and the art of remission maintenance.
    de Lima M; Roboz GJ; Platzbecker U; Craddock C; Ossenkoppele G
    Blood Rev; 2021 Sep; 49():100829. PubMed ID: 33832807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission.
    Wei AH; Döhner H; Pocock C; Montesinos P; Afanasyev B; Dombret H; Ravandi F; Sayar H; Jang JH; Porkka K; Selleslag D; Sandhu I; Turgut M; Giai V; Ofran Y; Kizil Çakar M; Botelho de Sousa A; Rybka J; Frairia C; Borin L; Beltrami G; Čermák J; Ossenkoppele GJ; La Torre I; Skikne B; Kumar K; Dong Q; Beach CL; Roboz GJ;
    N Engl J Med; 2020 Dec; 383(26):2526-2537. PubMed ID: 33369355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance therapies in acute myeloid leukemia: the renaissance of an old therapeutic concept.
    Bewersdorf JP; Tallman MS; Stahl M
    Curr Opin Oncol; 2021 Nov; 33(6):658-669. PubMed ID: 34341323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted and cytotoxic therapies as maintenance treatment for non-transplant eligible patients with acute myeloid leukemia.
    Patel SA; Litzow MR; Cerny J
    Blood Rev; 2021 Nov; 50():100863. PubMed ID: 34210571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance therapy for acute myeloid leukemia: sustaining the pursuit for sustained remission.
    Shallis RM; Podoltsev NA
    Curr Opin Hematol; 2021 Mar; 28(2):110-121. PubMed ID: 33394722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance therapy in AML: The past, the present and the future.
    Molica M; Breccia M; Foa R; Jabbour E; Kadia TM
    Am J Hematol; 2019 Nov; 94(11):1254-1265. PubMed ID: 31429099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral Azacitidine (CC-486) for the Treatment of Myeloid Malignancies.
    Garcia-Manero G; Döhner H; Wei AH; La Torre I; Skikne B; Beach CL; Santini V
    Clin Lymphoma Myeloma Leuk; 2022 Apr; 22(4):236-250. PubMed ID: 34758945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance therapy in acute myeloid leukemia: What is the future?
    McMahon CM; Luger SM
    Semin Hematol; 2019 Apr; 56(2):102-109. PubMed ID: 30926085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revisiting maintenance therapy in acute myeloid leukemia with novel agents.
    Canaani J; Luger SM
    Curr Opin Hematol; 2016 Mar; 23(2):175-80. PubMed ID: 26766539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial.
    Ravandi F; Roboz GJ; Wei AH; Döhner H; Pocock C; Selleslag D; Montesinos P; Sayar H; Musso M; Figuera-Alvarez A; Safah H; Tse W; Sohn SK; Hiwase D; Chevassut T; Pierdomenico F; La Torre I; Skikne B; Bailey R; Zhong J; Beach CL; Dombret H
    J Hematol Oncol; 2021 Aug; 14(1):133. PubMed ID: 34454540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a role for therapy after transplant?
    Oran B
    Best Pract Res Clin Haematol; 2015; 28(2-3):124-32. PubMed ID: 26590769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and emerging therapies for acute myeloid leukemia.
    Robak T; Wierzbowska A
    Clin Ther; 2009; 31 Pt 2():2349-70. PubMed ID: 20110045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.
    Xuan L; Liu Q
    J Hematol Oncol; 2021 Jan; 14(1):4. PubMed ID: 33407700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal Residual Disease Eradication by Azacitidine Maintenance in a Patient with Core-Binding Factor Acute Myeloid Leukemia.
    Yucel OK; Alemdar MS; Atas U; Undar L
    Chemotherapy; 2020; 65(5-6):166-170. PubMed ID: 33316797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOHO State of the Art Updates and Next Questions |The Role of Maintenance Therapy in Acute Myeloid Leukemia.
    Babakhanlou R; Ravandi-Kashani F
    Clin Lymphoma Myeloma Leuk; 2023 Jan; 23(1):1-7. PubMed ID: 36456394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypomethylating agents as maintenance therapy following allogeneic hematopoietic cell transplantation for myeloid malignancies.
    Appelbaum FR
    Best Pract Res Clin Haematol; 2021 Mar; 34(1):101241. PubMed ID: 33762112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance therapy with hypomethylating agents for patients with acute myeloid leukemia in first remission not eligible for allogeneic hematopoietic cell transplantation: A systematic review and meta-analysis.
    Sherban A; Raanani P; Gurion R; Wolach O; Gafter-Gvili A
    Leuk Res; 2022 Feb; 113():106773. PubMed ID: 35066294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Maintenance Chemotherapy with 6-Mercaptopurine and Methotrexate in Patients with Acute Myeloid Leukemia Ineligible for Transplantation.
    Choi YW; Jeong SH; Ahn MS; Lee HW; Kang SY; Choi JH; Park JS
    J Korean Med Sci; 2015 Oct; 30(10):1416-22. PubMed ID: 26425037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysis.
    Versluis J; Hazenberg CL; Passweg JR; van Putten WL; Maertens J; Biemond BJ; Theobald M; Graux C; Kuball J; Schouten HC; Pabst T; Löwenberg B; Ossenkoppele G; Vellenga E; Cornelissen JJ;
    Lancet Haematol; 2015 Oct; 2(10):e427-36. PubMed ID: 26686044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the Study Alliance Leukemia.
    Müller-Tidow C; Tschanter P; Röllig C; Thiede C; Koschmieder A; Stelljes M; Koschmieder S; Dugas M; Gerss J; Butterfaß-Bahloul T; Wagner R; Eveslage M; Thiem U; Krause SW; Kaiser U; Kunzmann V; Steffen B; Noppeney R; Herr W; Baldus CD; Schmitz N; Götze K; Reichle A; Kaufmann M; Neubauer A; Schäfer-Eckart K; Hänel M; Peceny R; Frickhofen N; Kiehl M; Giagounidis A; Görner M; Repp R; Link H; Kiani A; Naumann R; Brümmendorf TH; Serve H; Ehninger G; Berdel WE; Krug U;
    Leukemia; 2016 Mar; 30(3):555-61. PubMed ID: 26522083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.